Faculty Disclosures
| Richard M. Ransohoff, MD |
Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care. |
| Rana Karabudak, MD |
Dr. Karabudak has nothing to disclose. |
| Aksel Siva, MD |
Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants. |
| Massimo Filippi, MD, FAAN |
Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla. |
| Pablo Villoslada, MD, PhD, FAAN |
Dr. Villoslada has received personal compensation for serving as an employee of Attune Neuroscience. Dr. Villoslada has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Accure Therapeutics. Dr. Villoslada has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has stock in Attune Neurosciences. Dr. Villoslada has stock in Bionure Investments. Dr. Villoslada has stock in Spiral Therapeutics. Dr. Villoslada has stock in Adhera Health. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from NIH. The institution of Dr. Villoslada has received research support from Department of Defense. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care. |
| Filippo Martinelli Boneschi |
No disclosure on file
|
| Taskin Duman |
Dr. Duman has nothing to disclose. |
| Giovanni Castelnovo |
No disclosure on file
|
| Fredrik L. Piehl, MD, PhD |
Dr. Piehl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parexel/Chugai. The institution of Dr. Piehl has received research support from UCB. The institution of Dr. Piehl has received research support from Merck KGaA. Dr. Piehl has received personal compensation in the range of $10,000-$49,999 for serving as a member scientific advisory board with Swedish Medical products Agency. |
| Ari Green, MD |
Dr. Green has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline Therapeutics. Dr. Green has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from NINDS. The institution of Dr. Green has received research support from NMSS. The institution of Dr. Green has received research support from NIA. The institution of Dr. Green has received research support from Adelson Research Foundation. Dr. Green has received intellectual property interests from a discovery or technology relating to health care. Dr. Green has received personal compensation in the range of $500-$4,999 for serving as a Study Section with NINDS. Dr. Green has a non-compensated relationship as a Author with Viela Bio that is relevant to AAN interests or activities. |
| Omer F. Turan, MD |
Dr. Turan has nothing to disclose. |
| Roland Liblau |
Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Roland Liblau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-genzyme. Roland Liblau has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Servier. Roland Liblau has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Immunology. The institution of Roland Liblau has received research support from Roche. The institution of Roland Liblau has received research support from ARSEP. The institution of Roland Liblau has received research support from Fondation pour la Recherche Médicale. The institution of Roland Liblau has received research support from Population Bio UK, Inc. The institution of Roland Liblau has received research support from ANR. |
| Sergio Baranzini |
Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Sergio Baranzini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono . Sergio Baranzini has stock in MATE Bioservices. The institution of Sergio Baranzini has received research support from Valhalla Charitable Fund. The institution of Sergio Baranzini has received research support from Salah Foundation. The institution of Sergio Baranzini has received research support from NIH. The institution of Sergio Baranzini has received research support from NSF. Sergio Baranzini has received intellectual property interests from a discovery or technology relating to health care. Sergio Baranzini has a non-compensated relationship as a co-funder with Mate Bioservices that is relevant to AAN interests or activities. |
| Jens Kuhle, MD |
Dr. Kuhle has nothing to disclose. |
| Paola Cavalla |
No disclosure on file
|
| Helen E. Stephens |
No disclosure on file
|
| Murat Terzi, PhD |
Dr. Terzi has nothing to disclose. |
| Husnu Efendi, MD |
The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alexion. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Roche. The institution of Dr. Efendi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Novartis. |
| Annette Bang Oturai, MD |
Dr. Oturai has nothing to disclose. |
| Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN |
Dr. De Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurology Academy. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. De Luca has received research support from NIHR, BRC (Oxford). The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from UK MS Society. The institution of Dr. De Luca has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. De Luca has received research support from US Department of Defense. The institution of Dr. De Luca has received research support from Wellcome ISSF (Oxford). The institution of Dr. De Luca has received research support from Bristol Myers Squibb. The institution of Dr. De Luca has received research support from University of Oxford (John Fell Fund). The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). Dr. De Luca has a non-compensated relationship as a Editorial board member with MS Journal that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Vice-Chair of Grant Review Panel with UK MS Society that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Steering Group member with MS Academy that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Board of Directors with SEQUINS that is relevant to AAN interests or activities. |
| Federica Esposito |
Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care. |
| Amanda L. Piquet, MD, FAAN |
The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Novartis. The institution of Dr. Piquet has received research support from Abbvie. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to AAN interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to AAN interests or activities. |
| Helle B. Sondergaard, PhD |
Dr. Sondergaard has nothing to disclose. |
| Pavan Bhargava, MD, FAAN |
The institution of Dr. Bhargava has received research support from EMD Serono. The institution of Dr. Bhargava has received research support from Amylyx pharmaceuticals. The institution of Dr. Bhargava has received research support from Genentech. The institution of Dr. Bhargava has received research support from GSK. |
| Barbara Nuesslein-Hildesheim, PhD |
Dr. Nuesslein-Hildesheim has received personal compensation for serving as an employee of Novartis Pharma AG. Dr. Nuesslein-Hildesheim has stock in Novartis Pharma AG. |
| Nai-Wen Tsai, MD |
No disclosure on file
|
| Ugur Uygunoglu |
Ugur Uygunoglu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Turkey . The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen Idec/Gen Pharma of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck-Serono of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanovel of Turkey. The institution of Ugur Uygunoglu has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Genveon of Turkey. |
| Ufuk Aluclu, PhD |
No disclosure on file
|
| Marc Bigaud |
Marc Bigaud has received personal compensation for serving as an employee of Novartis Pharma. |
| Sara Llufriu |
Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merci. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbot. Sara Llufriu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. |
| Syed W. Akhtar, MD |
No disclosure on file
|
| Adil Harroud, MD |
Dr. Harroud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Harroud has received research support from National Multiple Sclerosis Society. The institution of Dr. Harroud has received research support from Multiple Sclerosis Society of Canada. |
| Xavier Ayrignac |
Xavier Ayrignac has nothing to disclose. |
|
No disclosure on file
|
| Sam H. Horng, MD, PhD |
The institution of Dr. Horng has received research support from National Institutes of Health . The institution of Dr. Horng has received research support from Jayne and Harvey Beker Foundation . |
| Jackson A. Narrett, MD |
Mr. Narrett has nothing to disclose. |
| Antonio Gallo |
Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. |
| Haluk Gumus |
No disclosure on file
|
| Cavit Boz, MD |
Dr. Boz has nothing to disclose. |
| Christian Cordano, MD, PhD |
Dr. Cordano has nothing to disclose. |
| Tuncay Gunduz, MD |
Dr. Gunduz has nothing to disclose. |
| Beatrice Pignolet |
Beatrice Pignolet has nothing to disclose. |
| Marco Pisa, MD |
Dr. Pisa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. |
| Asli Tuncer |
No disclosure on file
|
| Bernd C. Kieseier, MD |
Dr. Kieseier has received personal compensation for serving as an employee of Novartis. Dr. Kieseier has stock in Novartis. |
| Sedat Sen |
No disclosure on file
|
| Andrew Lockhart, MB, BAO, BCh, MSc |
The institution of Dr. Lockhart has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. Lockhart has received research support from European Charcot Foundation. |
| Elif Everest, PhD |
Ms. Everest has received personal compensation in the range of $50,000-$99,999 for serving as a postdoctoral visiting fellow with National Institutes of Health. |
| Jonah Chan, PhD |
Jonah Chan, PhD has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Pipeline Therapeutics. Jonah Chan, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SFN. Jonah Chan, PhD has stock in Pipeline Therapeutics. The institution of Jonah Chan, PhD has received research support from Mead Johnson. Jonah Chan, PhD has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with NIH/NINDS. |
| Mehmet Tecellioglu |
No disclosure on file
|
| Alex D. Waldman |
The institution of Mr. Waldman has received research support from European Charcot Foundation. The institution of Mr. Waldman has received research support from United States Department of Defense. The institution of Mr. Waldman has received research support from MS Treatment, 好色先生, and Research. |
| Antonino Giordano |
Mr. Giordano has nothing to disclose. |
| Caner Feyzi Demir |
Caner Feyzi Demirkaya has nothing to disclose. |
| Melih Tutuncu, MD |
Dr. Tutuncu has nothing to disclose. |
| Shane Arsenault, MD |
Dr. Arsenault has nothing to disclose. |
| Cihat Uzunkopru |
Cihat Uzunkopru has nothing to disclose. |
| Frederike Cosima Oertel, MD |
The institution of Dr. Oertel has received research support from AAN. The institution of Dr. Oertel has received research support from Hertie Foundation. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ECTRIMS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with NMSS. Dr. Oertel has received personal compensation in the range of $500-$4,999 for serving as a Recipient (Travel Grant) with ACTRIMS. |
| Ahmed Abdelhak, MD |
The institution of Dr. Abdelhak has received research support from German Multiple Sclerosis Society. |
| Jonathan Pansieri, PhD |
The institution of Dr. Pansieri has received research support from UK-MS society. The institution of Dr. Pansieri has received research support from Department of Defense US. Dr. Pansieri has received personal compensation in the range of $0-$499 for serving as a member of the Grant review Panel with French National Agency. Dr. Pansieri has received personal compensation in the range of $500-$4,999 for serving as a recipee of Travel Grant with Brain. |
| Sena Destan Bunul |
No disclosure on file
|
| Serkan Demir, MD |
Dr. Demir has nothing to disclose. |
| Thomas M. Angell |
Mr. Angell has nothing to disclose. |
| Gabriel A. Cerono |
Dr. Cerono has nothing to disclose. |
| Jefte Drijvers |
No disclosure on file
|
| Sandra D'Alfonso |
No disclosure on file
|
| Elisabetta Mascia |
No disclosure on file
|
| Elliott Ridgeon |
No disclosure on file
|
| Alissa Gutnikova |
No disclosure on file
|
| Richard Hickman |
No disclosure on file
|
| Margaret Esiri |
No disclosure on file
|
| Melissa Sorosina |
No disclosure on file
|
| Ingrid Kockum |
No disclosure on file
|
| Sabahattin Saip |
Sabahattin Saip has nothing to disclose. |
| Osman Sezerman |
No disclosure on file
|
| Eda Turanli |
The institution of Eda Turanli has received research support from Scientific and Technological Research Council of Turkey (TÜBITAK). The institution of Eda Turanli has received research support from Turkish MS Society. The institution of Eda Turanli has received research support from Acibadem University Scientific Research Projects Commission . The institution of Eda Turanli has received research support from Istanbul University Scientific Research Projects Commission . |
| Alper Bulbul |
Alper Bulbul has nothing to disclose. |
| Anna Olsson |
No disclosure on file
|
| Pamela Ramseier |
No disclosure on file
|
| Sarah Tisserand |
No disclosure on file
|
| Mario Amatruda |
No disclosure on file
|
| Bruno Cenni, PhD |
No disclosure on file
|
| Alexandra Beaudry-richard |
Alexandra Beaudry-richard has received research support from the Multiple Sclerosis Society of Canada. Alexandra Beaudry-richard has received research support from the Canadian Institutes of Health Research . |
| Bernhard Hemmer |
No disclosure on file
|
| Maja Jagodic |
No disclosure on file
|
| Jorge Villavicencio |
No disclosure on file
|
| Maria Needhamsen |
No disclosure on file
|
| Klementy Shchetynsky |
No disclosure on file
|
| Pernilla Stridh |
No disclosure on file
|
| Tatjana Uffelmann |
No disclosure on file
|
| Yanbo Zhang |
No disclosure on file
|
| Jeremy Burns |
No disclosure on file
|
| Elissa Murphy |
No disclosure on file
|
| Niranjana Nagarajan |
No disclosure on file
|
| Jiang Zhu |
No disclosure on file
|
| Christina Strange |
No disclosure on file
|
| Conor O'Malley |
No disclosure on file
|
| Kirtana Ananth |
No disclosure on file
|
| Ben Emery |
No disclosure on file
|
| Henriette Reinsberg |
No disclosure on file
|
| Sonia Nocera |
No disclosure on file
|
| Joshua Lengieza |
No disclosure on file
|
| Juliana Barrios |
No disclosure on file
|
| Katie Emberley |
No disclosure on file
|
| Greg Duncan |
No disclosure on file
|
| Trent Watkins |
No disclosure on file
|
| Kiarra Ning |
No disclosure on file
|
| Giuseppe Locatelli |
No disclosure on file
|
| Stephen Sofen |
No disclosure on file
|
| Ellen Cahir-McFarland |
No disclosure on file
|
| Enoch Kisubika |
No disclosure on file
|
| Katie Callow |
No disclosure on file
|
| Eugene Antipov |
No disclosure on file
|
| Stephanie Woodall |
No disclosure on file
|
| Joanna Pizzo |
No disclosure on file
|
| Mehmet Fatih Yetkin |
Mehmet Fatih Yetkin has nothing to disclose. |
| Steffan Bos |
No disclosure on file
|
| Hanne H |
No disclosure on file
|
| Stephan Beck |
No disclosure on file
|
| Nora Jabassini |
No disclosure on file
|
| Devan Moodley |
No disclosure on file
|
| Tone Berge |
No disclosure on file
|
| Kimmo Pääkkönen |
No disclosure on file
|
| Nadia Barizzone |
No disclosure on file
|
| Clara Limbaeck |
Clara Limbaeck has nothing to disclose. |
| Iaroslav Zinevych |
No disclosure on file
|
| Päivi Lahermo |
No disclosure on file
|
| Aimee Avery |
The institution of Aimee Avery has received research support from UK MS Society. The institution of Aimee Avery has received research support from US Deparment of Defense. |
| Timothy Nelson |
No disclosure on file
|
| Geetha Mylvaganam |
No disclosure on file
|
| Umut Voyvoda |
Umut Voyvoda has nothing to disclose. |
| Christiane Gasperi |
No disclosure on file
|
| Paula Uibel |
No disclosure on file
|
| Martina Flaskamp |
No disclosure on file
|
| Elena Chinni |
No disclosure on file
|
| Yizhou Wang |
No disclosure on file
|
| Fang Xia |
No disclosure on file
|
| Larry Schweitzer |
No disclosure on file
|
| Stefan Herrera |
No disclosure on file
|
| Bethan Chilton |
No disclosure on file
|
| CJ Ives |
No disclosure on file
|
| Stefan Gustavsen |
No disclosure on file
|
| Yuan Feng |
No disclosure on file
|
| Grace Voorhees |
No disclosure on file
|
| Matthias John |
No disclosure on file
|
| Michelle Fleury |
No disclosure on file
|
| Andrea Van Elsas |
No disclosure on file
|
| Amina Abbadi |
No disclosure on file
|
| Janna Saarela |
No disclosure on file
|
| Benedicte Dubois |
No disclosure on file
|
| Richard Zhou |
No disclosure on file
|